Aaron M. Cook

5.3k total citations · 1 hit paper
152 papers, 3.3k citations indexed

About

Aaron M. Cook is a scholar working on Neurology, Pediatrics, Perinatology and Child Health and Pharmacology. According to data from OpenAlex, Aaron M. Cook has authored 152 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Neurology, 22 papers in Pediatrics, Perinatology and Child Health and 20 papers in Pharmacology. Recurrent topics in Aaron M. Cook's work include Traumatic Brain Injury and Neurovascular Disturbances (24 papers), Epilepsy research and treatment (16 papers) and Pharmacological Effects and Toxicity Studies (15 papers). Aaron M. Cook is often cited by papers focused on Traumatic Brain Injury and Neurovascular Disturbances (24 papers), Epilepsy research and treatment (16 papers) and Pharmacological Effects and Toxicity Studies (15 papers). Aaron M. Cook collaborates with scholars based in United States, United Kingdom and Mexico. Aaron M. Cook's co-authors include Jimmi Hatton, Kyle A. Weant, John J. Lewin, Monisha A. Kumar, Michael Stiefel, Richard J. Gilbert, Jennifer Frontera, Gregory J. del Zoppo, Anne W. Alexandrov and Alejandro A. Rabinstein and has published in prestigious journals such as Nature, SHILAP Revista de lepidopterología and Applied and Environmental Microbiology.

In The Last Decade

Aaron M. Cook

144 papers receiving 3.1k citations

Hit Papers

Guideline for Reversal of Antithrombotics in Intracranial... 2015 2026 2018 2022 2015 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aaron M. Cook United States 28 845 587 474 428 307 152 3.3k
Andrea Fabbri Italy 37 525 0.6× 1.2k 2.0× 192 0.4× 589 1.4× 471 1.5× 188 4.3k
David Bar‐Or United States 38 658 0.8× 740 1.3× 654 1.4× 902 2.1× 1.0k 3.4× 242 5.5k
Sarah L. Booth United States 64 1.7k 2.0× 715 1.2× 768 1.6× 1.2k 2.9× 78 0.3× 237 14.3k
Tao Liu China 29 1.7k 2.0× 494 0.8× 1.6k 3.3× 865 2.0× 198 0.6× 173 5.8k
Marc Moss United States 44 686 0.8× 1.1k 1.8× 1.5k 3.1× 337 0.8× 488 1.6× 159 7.7k
Johan Mårtensson Sweden 38 329 0.4× 1.3k 2.1× 616 1.3× 528 1.2× 555 1.8× 169 5.4k
James J. DiNicolantonio United States 49 320 0.4× 707 1.2× 1.5k 3.2× 1.1k 2.6× 161 0.5× 194 6.9k
W. Stephen Waring United Kingdom 37 126 0.1× 358 0.6× 508 1.1× 675 1.6× 644 2.1× 147 4.1k
Patrick Blin France 30 114 0.1× 580 1.0× 662 1.4× 258 0.6× 156 0.5× 152 3.4k
Stephen W. Borron France 39 208 0.2× 290 0.5× 317 0.7× 369 0.9× 1.6k 5.1× 104 4.3k

Countries citing papers authored by Aaron M. Cook

Since Specialization
Citations

This map shows the geographic impact of Aaron M. Cook's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aaron M. Cook with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aaron M. Cook more than expected).

Fields of papers citing papers by Aaron M. Cook

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aaron M. Cook. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aaron M. Cook. The network helps show where Aaron M. Cook may publish in the future.

Co-authorship network of co-authors of Aaron M. Cook

This figure shows the co-authorship network connecting the top 25 collaborators of Aaron M. Cook. A scholar is included among the top collaborators of Aaron M. Cook based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aaron M. Cook. Aaron M. Cook is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cook, Aaron M., et al.. (2025). Update on Neuroprotection after Traumatic Brain Injury. CNS Drugs. 39(5). 473–484. 3 indexed citations
2.
Jones, G. Morgan, Aaron M. Cook, Gary D. Peksa, et al.. (2025). Reversal of Factor Xa Inhibitor-Related Intracranial Hemorrhage: A Multicenter, Retrospective, Observational Study Comparing the Efficacy and Safety of Andexanet and Prothrombin Complex Concentrates. Critical Care Medicine. 53(6). e1202–e1213. 1 indexed citations
3.
Johnson, Eric, et al.. (2025). Evaluation of post-craniotomy headache management: A single-center retrospective study. Journal of Clinical Neuroscience. 135. 111160–111160.
4.
Rhoney, Denise H., Aaron M. Cook, Karen Berger, et al.. (2025). The Evolution of Neurocritical Care Pharmacy: Historical Perspectives and Future Horizons. Neurocritical Care. 43(1). 318–332.
5.
Cook, Aaron M., et al.. (2025). Levetiracetam Dosing Optimization in Neurocritical Care Population: Neuro-ARC Study. Neurocritical Care. 43(3). 887–901.
6.
Cook, Aaron M., et al.. (2024). Publication of pharmacy resident research projects: A systematic review and meta-analysis. American Journal of Health-System Pharmacy. 81(16). 713–722. 2 indexed citations
7.
Cook, Aaron M., et al.. (2023). Personalized antiseizure medication therapy in critically ill adult patients. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 43(11). 1166–1181. 4 indexed citations
8.
Cook, Aaron M., et al.. (2023). Methadone Maintenance Therapy after Aneurysmal Subarachnoid Hemorrhage: A Case Report. SHILAP Revista de lepidopterología. 21(1).
9.
Flannery, Alexander H., et al.. (2020). First‐Dose Vancomycin Pharmacokinetics Versus Empiric Dosing on Area‐Under‐the‐Curve Target Attainment in Critically Ill Patients. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 40(12). 1210–1218. 7 indexed citations
10.
Cook, Aaron M., et al.. (2019). Augmented Renal Clearance. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 39(3). 346–354. 110 indexed citations
11.
Schadler, Aric, et al.. (2019). Predicting Bleeding and Thrombosis Complications in Patients with Continuous Flow Left Ventricular Assist Devices. Digital Commons-TMC (Texas Medical Center). 6(1). 1 indexed citations
12.
Lewin, John J., Aaron M. Cook, Ron Neyens, et al.. (2018). Current Practices of Intraventricular Antibiotic Therapy in the Treatment of Meningitis and Ventriculitis: Results from a Multicenter Retrospective Cohort Study. Neurocritical Care. 30(3). 609–616. 36 indexed citations
13.
Zafar, Muhammad Shahzad, et al.. (2018). Continuous Intravenous Valproate as Abortive Therapy for Pediatric Status Migrainosus. The Neurologist. 23(2). 43–46. 14 indexed citations
14.
Cook, Aaron M., et al.. (2015). Pharmacokinetics and Clinical Utility of Valproic Acid Administered via Continuous Infusion. CNS Drugs. 30(1). 71–77. 10 indexed citations
16.
McConeghy, Kevin W., Jimmi Hatton, Lindsey Hughes, & Aaron M. Cook. (2012). A Review of Neuroprotection Pharmacology and Therapies in Patients with Acute Traumatic Brain Injury. CNS Drugs. 26(7). 613–636. 133 indexed citations
17.
Weant, Kyle A., et al.. (2010). High-Dose Methylprednisolone in Acute Spinal Cord Injuries: Proceed With Caution. Orthopedics. 33(5). 327–331. 12 indexed citations
18.
Boyer, Edward W., et al.. (2010). Conducting Drug Abuse Investigations in Natural Environments: Potential Directions for Medical Toxicology Research. Journal of Medical Toxicology. 6(1). 56–62. 1 indexed citations
19.
Cook, Aaron M., et al.. (2009). Cyclosporine A for neuroprotection: establishing dosing guidelines for safe and effective use. Expert Opinion on Drug Safety. 8(4). 411–419. 32 indexed citations
20.
Denger, Karin, Theo H. M. Smits, & Aaron M. Cook. (2006). Genome-enabled analysis of the utilization of taurine as sole source of carbon or of nitrogen by Rhodobacter sphaeroides 2.4.1. Microbiology. 152(11). 3197–3206. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026